BMC Ophthalmology 2025; 25(1): 251 |
Xu Jiangning et al.
Hereditary amyloid transthyretin (hATTR) is a progressive autosomal dominant disease caused by genetic variants of transthyretin (TTR) [1, 2–3]. Different manifestations are caused by mutant TTR...
Journal of the American College of Cardiology 2025; 85(27 May 2025): 1943-55 |
Sheikh, Farooq H. et al.
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) progressively impairs functional capacity, health status, and quality of life (QOL). In HELIOS-B (A Study to Evaluate Vutrisiran in Patients With...
Amyloid 2025; 32(1): 54-62 |
Katharina
Knoll
a
b
et al.
Wild-type transthyretin cardiac amyloidosis (ATTRwt) is an infiltrative disease leading to restrictive cardiomyopathy. We aimed to characterise exercise capacity in ATTRwt and to identify predictors of...
By requesting access to the "ATTR Expert" service, I agree that GNM Healthcare Consulting France SAS may use the data acquired during my access request to provide me with twice per month
information related to its services in accordance with the
Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to
dpo@gnmhealthcare.com.
You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.
